Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: November 30, 2015

Work could eventually lead to cell transplants for people blinded by glaucoma, MS

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain.

Released: November 25, 2015

Mipp1 protein helps cells sprout “fingers” for gripping

Fruit fly windpipes are much more like human blood vessels than the entryway to human lungs. To create that intricate network, fly embryonic cells must sprout “fingers” and crawl into place. Now researchers at The Johns Hopkins University have discovered that a protein called Mipp1 is key to cells’ ability to grow these fingers.

Released: November 25, 2015

Before the fluid of the middle ear drains and sound waves penetrate for the first time, the inner ear cells of newborn rodents practice for their big debut. Researchers at Johns Hopkins report they have figured out the molecular chain of events that enables the cells to make “sounds” on their own, essentially “practicing” their ability to process sounds in the world around them.

Released: November 25, 2015

Richard T. Johnson, an internationally renowned Johns Hopkins neurologist who is credited with inventing the field of neurovirology — the study of viruses that infect the nervous system — died at The Johns Hopkins Hospital on November 22 of pneumonia.

Released: November 24, 2015

Hal Dietz, M.D., of the Johns Hopkins University School of Medicine, has received the 2015 Research Achievement Award from the American Heart Association “for lifesaving discoveries related to the cause and treatment of aortic aneurysm, a disorder that contributes to death in up to 2 percent of individuals in industrialized nations of the world.”

Released: November 23, 2015

Four Johns Hopkins Medicine hospitals have been honored as leaders in care by the Joint Commission’s 2014 Top Performer on Key Quality Measures program.

Released: November 19, 2015

Drug companies exploit subsidies and tax breaks never intended for “blockbuster” medicines

Health experts at Johns Hopkins Medicine are calling on lawmakers and regulators to close loopholes in the Orphan Drug Act they claim give drug companies millions of dollars in unintended and misplaced subsidies and tax breaks and fuel skyrocketing medication costs.

Released: November 19, 2015

As we age or develop neurodegenerative diseases such as Alzheimer's, our brain cells may not produce sufficient energy to remain fully functional. Researchers discovered that an enzyme called SIRT3 that is located in mitochondria — the cell's powerhouse — may protect mice brains against the kinds of stresses believed to contribute to energy loss. Furthermore, mice that ran on a wheel increased their levels of this protective enzyme. 

Released: November 17, 2015

In a “look-back” analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts. A report on the findings is published in the November issue of Gastroenterology.

Released: November 17, 2015

Overall risk remains very low, researchers say

Although the vast majority of pediatric spine surgeries are safe, a handful of neuromuscular conditions seem to fuel the risk of cardiac arrest during such operations, according to research led by investigators at the Johns Hopkins Children’s Center.

Released: November 16, 2015

Study results show it’s a good alternative to laser therapy, and with fewer side effects

In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease.

Released: November 15, 2015

Case highlights acute need for better understanding and creative treatment of pediatric tuberculosis

Johns Hopkins Children’s Center specialists report they have successfully treated and put in remission a 2-year-old, now age 5, with a highly virulent form of tuberculosis known as XDR TB, or extensively drug-resistant TB.

Released: November 12, 2015

Opening doors too often can interfere with airflow systems that reduce infection risk

A “secret shopper” style study by researchers at Johns Hopkins analyzing foot traffic in and out of operating rooms suggests that for the sake of patient safety, OR teams may want to stay put more often.

Released: November 12, 2015

Findings could advance stem cell therapy for heart disease

Johns Hopkins researchers report that a new study of mouse cells has revealed reasons why attempts to grow stem cells to maturity in the laboratory often fail, and provided a possible way to overcome such “developmental arrest.”

Released: November 12, 2015

New method expected to speed understanding of short telomere diseases and cancer

Since the Nobel Prize-winning discovery of the enzyme telomerase in 1984, identifying other biological molecules that lengthen or shorten the protective caps on the ends of chromosomes has been slow going. Now, researchers at Johns Hopkins report uncovering the role of an enzyme crucial to telomere length and say the new method they used to find it should speed discovery of other proteins and processes that determine telomere length. 

Released: November 10, 2015

Study conducted in human breast cell cultures and mice

Results of a new laboratory study by Johns Hopkins Kimmel Cancer Center researchers suggests that some rare “missense” mutations in the HER2 gene are apparently not — on their own — capable of causing breast cancer growth or spread. In a related finding, the research team said such mutations, which are found in about 5 percent of breast cancers, may, thus, also fail to predict response to anti-cancer drugs that target the HER2 gene, unlike the more common alterations of the gene that amplify or overexpress it.
Released: November 9, 2015

A major source of American health information data contains a handful of glaring flaws related to health risks, say Johns Hopkins researchers in a study published online Wednesday in the journal PLOS ONE.

Released: November 9, 2015

Some nerve cells in the inner ear can signal tissue damage in a way similar to pain-sensing nerve cells in the body, according to new research from Johns Hopkins. If the finding, discovered in rats, is confirmed in humans, it may lead to new insights into hyperacusis, an increased sensitivity to loud noises that can lead to severe and long-lasting ear pain.

Released: November 3, 2015

On Tuesday, Nov. 3, experts in genetics, immunology, epidemiology, biology and pathology from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins will discuss their projections for the future of cancer research and the challenges and opportunities facing cancer doctors and patients today. Topics discussed during the forum, which will be held from 1 p.m. to 2:30 p.m. at the Kimmel Cancer Center’s Albert H. Owens Jr. Auditorium, may include the promise of research fields such as precision medicine, immunotherapy, and cancer prevention.